• Publications
  • Influence
18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
Although 18F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, the pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases. Expand
The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
The results of the present study provide further evidence that dual time point (18)F-FDG PET imaging is an important noninvasive method for the differentiation of malignant and nonmalignant lesions. Expand
Tyrosinase as a multifunctional reporter gene for Photoacoustic/MRI/PET triple modality molecular imaging
It is demonstrated that TYR gene can be utilized as a multifunctional reporter gene for PAI/MRI/PET both in vitro and in vivo. Expand
18F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study
18F-FDG PET/CT is helpful in the diagnosis of cardiac masses before treatment and has value in detecting extracardiac primary or secondary tumours and could also be a promising tool to provide prognostic information for these patients, especially SUVmax displaying independent prognostic value. Expand
Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment
Tumor-specific targeting was evidenced by reduced tumor uptake of nearly 70% on administration of a 10-fold excess of unlabeled UA20 scFv, demonstrating the potential for future development for prostate cancer imaging and targeted therapy. Expand
18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis
18F-FDG PET could be a potentially powerful non-invasive tool for predicting pathological response; the related parameters RI and SUVmax-post may be more suitable for the prediction of TRG than pCR. Expand
Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
It is demonstrated that low pSUVmax is associated with mutant EGFR status and could be integrated with other clinical factors to enhance the discriminability on the EGFR mutation status in some NSCLC patients whose EGFR testing is unavailable. Expand
Nuclear medicine services after COVID-19: gearing up back to normality
There are numerous studies ongoing in the attempt to find an effective vaccine and treatment for COVID-19, and there is significant heterogeneity in the degree of success of the various measures, in keeping with differing political, sociological, and economic factors around the world. Expand
Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer.
Upconversion nanoparticles (UCNPs) have been widely employed for tumor imaging using magnetic resonance imaging (MRI) and upconversion luminescence (UCL) imaging. The short blood clearance time andExpand
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.
Analysis of the findings suggests that FDG-PET has moderately high sensitivity and specificity in early detection of responders from nonresponders, and can be applied in the evaluation of breast cancer response to neoadjuvant chemotherapy in patients with breast cancer. Expand